John Lechleiter - 2009 CEO Pay

John Lechleiter - Eli Lilly

Total Compensation: $20.9 million

Details: Lechleiter became Lilly's chairman in 2009, which the committee considered when establishing his $1.48 million base salary, a 7 percent increase over 2008. His 2009 compensation also included $3.55 million in non-equity incentive plan compensation, $11.25 million in certain equity awards and $90,091 from a savings-plan match and tax reimbursements. He also holds shares valued at more than 11 times his salary. Lechleiter has asked that his base salary not be increased for 2010.

Eli Lilly News:
Pharma's $80B cost-cutting deal cuts Lilly sales forecasts
Lilly hit hard in $70M warehouse heist
Eli Lilly chief sees pay hike of 30%
Bristol, Lilly post double-digit sales hikes
Lilly strong now, but future uncertain

John Lechleiter - 2009 CEO Pay

Suggested Articles

Oklahoma politicians contend J&J should be on the line for future abatement costs even after a $572 million verdict, but J&J sees things differently.

Abbott helmsman Miles White, who oversaw the spinoffs of AbbVie and Hospira, will step down as CEO after 21 years at the top job.

Mylan is the most recent drugmaker facing the FDA's ire over a tainted API that led to a global recall of "sartan"-based drugs last year.